Medtronic drug-eluting stent advancing
MINNEAPOLIS, June 27 (UPI) -- Medtronic said Tuesday it has finished enrolling patients in a study of its drug-eluting coronary stent Endeavor.
The Endeavor IV trial is a head-to-head comparison of Medtronic's drug-eluting stent with Boston Scientific's Taxus stent. The company's Endeavor III study compared Medtronic's product to Johnson & Johnson's Cypher stent. 
· Read The Full Boston Scientific Taxus Stent Article From United Press International -->
·
Read All Boston Scientific Taxus Stent News Stories -->